Verdezyne to Synthesize Genes for Syngenta | GenomeWeb

NEW YORK (GenomeWeb News) — The synthetic biology company Verdezyne will develop novel genes for Syngenta, which will test them for enzyme expression in plants, Verdezyne said today.

Formerly called Coda Genomics, Verdezyne uses computational algorithms to design and synthesize gene libraries used to make proteins, metabolic pathways, and microorganisms, which are in turn used to make platform chemicals and biofuels.

Syngenta sells genetically modified plant seeds and biology-based crop protection technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.